Fresenius | FRE - Current Liabilities


Fresenius reported EUR8.38B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Akzo Nobel EUR 4.31B 77M Jun/2026
Alcon AG USD 3B 45M Mar/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
BASF EUR 20.91B 1.26B Jun/2026
Bayer EUR 33.46B 875M Mar/2026
Beiersdorf EUR 3.51B 261M Dec/2025
DaVita Healthcare Partners USD 2.86B 12.03M Jun/2026
Demant DKK 7.42B 1.63B Dec/2025
E.ON EUR 29.49B 1.4B Mar/2026
Essilor EUR 12.64B 490M Jun/2026
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Getinge SEK 12.03B 3.01B Jun/2026
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 21.53B 895M Jun/2026
GN Store Nord DKK 4.81B 2.5B Mar/2026
GRIFOLS EUR 2.24B 112M Jun/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.75B 374M Jun/2026
Philips EUR 7.42B 8M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
RWE EUR 36.24B 13.31B Mar/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Smith & Nephew USD 2.05B 510M Jun/2026